Argentina HIV Clinical Forum 2018 – Integrase Inhibitors

 

Thursday 13 September - Day 1

 Session 1
 HIV Integrase Inhibitors: A new mechanism of action
Charles Boucher, MD, PhD - Erasmus Medical Center, Rotterdam, The Netherlands
 
 Schapiro Photo 2008Resistance Characteristics of different Integrase Inhibitors
Jonathan Schapiro, MD - Sheba Medical Center, Ramat Ghan, Israel
(Not yet available)
 
  Session 2
 Pharmacology and new modes of delivery
David Back, PhD - University of Liverpool, Liverpool, United Kingdom
 
 Clinical use of Integrase Inhibitors
Eugenia Negredo, PhD - H. Univ. Germans Trias i Pujol, Badalona, Spain
 
 Session 3
 Use of Integrase Inhibitors in special populations
Omar Sued, MD, MsC, PhD - Fundación Huésped, Buenos Aires, Argentina
 
 Use of Integrase Inhibitors in Latin America
Mônica Jacques de Moraes, MD, PhD - UNIMED, Campinas, Brazil
 
 Dual therapy regimens
Maria Ines Figueroa, MD - Fundación Huésped, Buenos Aires, Argentina
 
 Negredo, Eugènia 2013 120x160Clinical case presentation
Eugenia Negredo, PhD - H. Univ. Germans Trias i Pujol, Badalona, Spain